There are a lot of reasons to be skeptical of tech investing right now since last year’s broad market selloff — just how far is the Fed planning to go with rising rates this year, anyway? Still, there is a place for a smart tech slice in investors’ portfolios, especially in companies disrupting and innovating [...] The post EXAS Nears Key Buy Signal in Active Biotech ETF ARKG appeared first on ETF Trends .